**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 844-51-9 |2,5-cyclohexadiene-1,4-dione, 2,5-diph| | 212-680-8 |
| |enyl- | | |
+----------------+--------------------------------------+----------+-----------+
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
The toxicological properties of this material have not been
investigated. Use appropriate procedures to prevent opportunities
for direct contact with the skin or eyes and to prevent inhalation.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower lids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of soap and water for at
least 15 minutes while removing contaminated clothing and shoes.
Remove contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure to fresh air
immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire.
Autoignition Temperature: Not available.
Flash Point: Not available.
NFPA Rating: Not published.
Explosion Limits, Lower: Not available.
Upper: Not available.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid
ingestion and inhalation.
Storage:
Store in a cool, dry place. Keep container closed when not in use.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other
engineering controls to control airborne levels.
Personal Protective Equipment
Eyes:
Wear chemical goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR ??1910.134 and ANSI Z88.2 requirements must be
followed whenever workplace conditions warrant a
respirator's use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Not available.
Appearance: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Vapor Density: Not available.
Evaporation Rate: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 211 deg C
Decomposition Temperature: Not available.
Solubility: Not available.
Specific Gravity/Density: Not available.
Molecular Formula: C18H12O2
Molecular Weight: 260.28
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, strong oxidants.
Incompatibilities with Other Materials:
Not available.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases.
Hazardous Polymerization: Not available.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 844-51-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2,5-cyclohexadiene-1,4-dione, 2,5-diphenyl- -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
For further information, contact Fisher Scientific.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
CDG/CPL
IMO
Not regulated as a hazardous material.
IATA
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
Canadian TDG
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 844-51-9:
Canada
CAS# 844-51-9 is listed on Canada's DSL/NDSL List.
WHMIS: Not available.
CAS# 844-51-9 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
US FEDERAL
TSCA
CAS# 844-51-9 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 2/28/1995 Revision #1 Date: 3/04/1996
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall Fisher be liable
for any claims, losses, or damages of any third party or for lost profits
or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if Fisher has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2,6-Pyridinedicarboxylic Acid Chloride, 97%
| 3739-94-4 |
|
OPD tablets, 120 mg/tablet
| 615-28-1 |
|
Tetrabutylphosphonium bromide, 98%
| 3115-68-2 |
|
2'-Deoxyguanosine 5'-Monophosphate, Sodium Salt Hydrate
| 52558-16-4 |
|
4-(Dimethylamino)pyridinium Bromide Perbromide
| 92976-81-3 |
|
Mercury(ii) thiocyanate, p.a.
| 592-85-8 |
|
Beta-Ionone, Synthetic, 96%
| 14901-07-6 |
|
Quercetin (Pract)
| 117-39-5 |
|
4-Chlorobenzotrichloride, 99%
| 5216-25-1 |
|
1-Iodopropane, 99%, Stabilized over Copper
| 107-08-4 |
|
2-Acetyl-1-methylpyrrole, 99%
| 932-16-1 |
|
4-Dimethylamino-4'-nitrostilbene
| 4584-57-0 |
|
Pentafluorothiophenol, 97%
| 771-62-0 |
|
1-(4-METHOXYPHENYL)-1-CYCLOPROPANE- CARBONITRILE
| 16728-00-0 |
|
Triphenylthioantimonate, 99%
| 28609-58-7 |
|
4-Methylthiazole, 99%
| 693-95-8 |
|
DL-2-Amino-1-Propanol, 98%
| 6168-72-5 |
|
2,5-Diphenyl-p-benzoquinone (pract), 93% (uv-vis)
| 844-51-9 |
|
4-Methylbenzyltriphenylphosphonium chloride, 99%
| 1530-37-6 |
|
L-(+)-Prolinol
| 23356-96-9 |
|
Prostaglandin VIII, 99%
| 0-01-1 |
|
Allyl alcohol
| 107-18-6 |
|
Phosphorus Tribromide, 99%
| 7789-60-8 |
|
5-Nitroisoquinoline, 98%
| 607-32-9 |
|
1,3-Acetonedicarboxylic acid, 96%
| 542-05-2 |
|
Pentacene, 98%
| 135-48-8 |
|
3,3'-Dimethoxybenzidine dihydrochloride, 99% (titr.)
| 20325-40-0 |
|
Diethyl Bis(hydroxymethyl)malonate, 95% (HPLC)
| 20605-01-0 |
|
P-Bromo-DL-Phenylalanine, 99%
| 14091-15-7 |
|
1,2-(Didodecyloxy)benzene, 98% (GC)
| 42244-53-1 |
|
p-Anisaldehyde, 99+%
| 123-11-5 |
|
Diazogen, 99%
| 80-11-5 |
|
2-Fluoro-4-Nitrotoluene, 98%
| 1427-07-2 |
|
Sodium triacetoxyborohydride
| 56553-60-7 |
|
Indole-2-carboxylic acid, 99%
| 1477-50-5 |
|
Pyridoxine Hydrochloride, 99% (Titr.)
| 58-56-0 |
|
2,6-Dichlorophenol
| 87-65-0 |
|
1,2-Butanediol, 98%
| 26171-83-5 |
|
2-(2-Aminoethoxy)ethanol, 98%
| 929-06-6 |
|
Poly(propylene Glycol), Average M.W. 425
| 25322-69-4 |
|
Valinomycin, 96% (HPLC)
| 2001-95-8 |
|
7-Amino-4-Methyl-1,8-Naphthyridin-2-ol, 98 %
| 1569-15-9 |
|
Benzyl butyrate, 98%
| 103-37-7 |
|
Lutetium oxide, 99.99%, -325 mesh
| 12032-20-1 |
|
P-Nitrophenyl Chloroformate, 96% (Titr.)
| 7693-46-1 |
|
Potassium sorbate, 99%
| 590-00-1 |
|
Phthalan, 97%
| 496-14-0 |
|
Cinnamyl Acetate, 99+%
| 103-54-8 |
|
Butyl Isocyanatoacetate, 98% (GC)
| 17046-22-9 |
|
Zirconyl(IV) chloride octahydrate, 98+%
| 7699-43-6 |
|
|